Publication | Closed Access

Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study

HypertensionCardiovascular DiseaseHypertensive PatientsMedicineAntihypertensive TherapyVascular PharmacologyCardiovascular PharmacologyVascular BiologyTissue Factor ActivityReceptor BlockersPharmacologyAtherosclerosisBlood Pressure